BAHD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.487400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.246600E-01
Normal-vs-Stage2
4.353600E-01
Normal-vs-Stage3
3.480400E-02
Normal-vs-Stage4
9.743400E-01
Stage1-vs-Stage2
2.851600E-01
Stage1-vs-Stage3
1.546220E-01
Stage1-vs-Stage4
4.367000E-01
Stage2-vs-Stage3
1.432160E-01
Stage2-vs-Stage4
3.516400E-01
Stage3-vs-Stage4
4.518300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.066400E-01
Normal-vs-AfricanAmerican
3.216800E-01
Normal-vs-Asian
1.797360E-01
Caucasian-vs-AfricanAmerican
6.244600E-01
Caucasian-vs-Asian
1.846040E-01
AfricanAmerican-vs-Asian
5.604000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.302200E-01
Normal-vs-Female
6.748600E-01
Male-vs-Female
9.907800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.684600E-01
Normal-vs-Age(41-60Yrs)
8.347200E-01
Normal-vs-Age(61-80Yrs)
4.864200E-01
Normal-vs-Age(81-100Yrs)
7.516500E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.536000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.122000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.738000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.320300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.39939999999917E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.026000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.850200E-01
Normal-vs-Daily Drinker
6.758800E-01
Normal-vs-Weekly Drinker
6.988400E-01
Normal-vs-Occasional Drinker
9.072600E-01
Normal-vs-Social Drinker
4.027000E-01
Non Drinker-vs-Daily Drinker
4.676000E-01
Non Drinker-vs-Weekly Drinker
5.617200E-01
Non Drinker-vs-Occasional Drinker
8.799700E-02
Non Drinker-vs-Social Drinker
8.196200E-01
Daily Drinker-vs-Weekly Drinker
9.757600E-01
Daily Drinker-vs-Occasional Drinker
3.438000E-01
Daily Drinker-vs-Social Drinker
6.690200E-01
Weekly Drinker-vs-Occasional Drinker
4.130600E-01
Weekly Drinker-vs-Social Drinker
7.333400E-01
Occasional Drinker-vs-Social Drinker
2.049800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.975780E-01
Normal-vs-Grade 2
9.595500E-03
Normal-vs-Grade 3
1.039530E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.920000E-01
Grade 1-vs-Grade 3
6.363800E-01
Grade 1-vs-Grade 4
1.975780E-01
Grade 2-vs-Grade 3
1.481180E-01
Grade 2-vs-Grade 4
9.595500E-03
Grade 3-vs-Grade 4
1.039530E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.092000E-01
Normal-vs-NonDiabetic
7.174200E-01
Diabetic-vs-NonDiabetic
7.151800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.216200E-01
Normal-vs-NoPancreatitis
6.824200E-01
Pancreatitis-vs-NoPancreatitis
1.540380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.798600E-01
Normal-vs-N1
4.678200E-01
N0-vs-N1
5.088400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.609000E-01
Normal-vs-TP53-NonMutant
8.581200E-01
TP53-Mutant-vs-TP53-NonMutant
9.351800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
